CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- RW Other RW
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- DRS Other Draft Registration Statement
- F-6/A Other F-6/A
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- EFFECT Other Notice of Effectiveness
- NT 10-K Other NT 10-K
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
Page 1 of 8 · 145 filings